Showing 1,281 - 1,300 results of 1,792 for search '(( 2 e decrease ) OR ( 10 ((((we decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 0.22s Refine Results
  1. 1281
  2. 1282
  3. 1283
  4. 1284
  5. 1285
  6. 1286
  7. 1287
  8. 1288
  9. 1289
  10. 1290
  11. 1291
  12. 1292

    CLINICAL AND ECONOMIC IMPACT OF GENETIC AND NON-GENETIC FACTORS ON INR NORMALIZATION IN PRE-OPERATIVE MANAGEMENT OF WARFARIN PATIENTS by ELJILANY, ISLAM AHMED SAYED AHMED

    Published 2021
    “…To optimize the period of preprocedural warfarin interruption to decrease the incidence of bleeding in case of bridging and the incidence of thromboembolism in case of non-bridging, a study was conducted to determine the influence of CYP2C9, VKORC1, CYP4F2, FII, and FVII genetic polymorphisms and non-genetic factors on INR decline in a cohort of Arabs undergoing a procedure that requires warfarin interruption and developing an algorithm to tailor the duration of warfarin interruption before the procedure. …”
    Get full text
  13. 1293
  14. 1294
  15. 1295
  16. 1296
  17. 1297

    Omega-3 fatty acid-rich fish oil supplementation prevents rosiglitazone-induced osteopenia in aging mice by Cugno, Chiara

    Published 2021
    “…Rosiglitazone is an effective insulin-sensitizer, however, associated with bone loss mainly due to increased bone resorption, and bone marrow adiposity, and decreased bone formation. We investigated the effect of the co-administration of fish oil (FO) rich in omega-3 fatty acids (FAs) on rosiglitazone (RSG)-induced bone loss in aging C57BL/6 mice and the mechanisms underlying potential preventive effect. …”
    Get full text
    Get full text
  18. 1298
  19. 1299
  20. 1300